Aclaris Therapeutics (ACRS) Interest Coverage Ratio (2014 - 2026)
Aclaris Therapeutics (ACRS) posted quarterly Interest Coverage Ratio of 1.51 for Q1 2026, up 93.8% year-over-year from 0.78 in Q1 2025, and up 42.84% quarter-over-quarter from 2.64 in Q4 2025.
Aclaris Therapeutics (ACRS) Interest Coverage Ratio (2014 - 2026) Analysis & Trends
Aclaris Therapeutics' Interest Coverage Ratio history runs 13 years deep, the most recent figure standing at 1.51 for Q1 2026.
- In Q1 2026, Interest Coverage Ratio rose 93.8% year-over-year to 1.51; the TTM figure through Mar 2026 stood at 5.48 (up 97.12% YoY), while the FY2025 annual figure was 0.39, up 38.75% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 1.51, up from 2.64 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 0.02 in Q4 2023, with the low at 129.27 in Q3 2024.
- The 5-year median for Interest Coverage Ratio is 6.31 (2023), against an average of 19.27.
- The sharpest annual moves came in 2023 and 2024: Interest Coverage Ratio soared 98.91% in 2023, then tumbled 161819.75% in 2024.
- Aclaris Therapeutics' Interest Coverage Ratio stood at 1.9 in 2022, then jumped by 98.91% to 0.02 in 2023, then sank by 161819.75% to 33.58 in 2024, then jumped by 92.13% to 2.64 in 2025, then soared by 42.84% to 1.51 in 2026.
- Business Quant data shows ACRS's Interest Coverage Ratio at 1.51 in Q1 2026, 2.64 in Q4 2025, and 7.95 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | Aclaris Therapeutics | 808.18 Mn | 716.63 Mn | 1.41 Mn | -0.75 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.75 |
| Mar 31, 2026 | -1.51 |
| Dec 31, 2025 | -2.64 |
| Sep 30, 2025 | -7.95 |
| Jun 30, 2025 | -36.38 |
| Mar 31, 2025 | -24.37 |
| Dec 31, 2024 | -33.58 |
| Sep 30, 2024 | -129.27 |
| Jun 30, 2024 | -26.84 |
| Mar 31, 2024 | -38.87 |
| Dec 31, 2023 | -0.02 |
| Sep 30, 2023 | -8.58 |
| Jun 30, 2023 | -4.95 |
| Mar 31, 2023 | -6.31 |
| Dec 31, 2022 | -1.90 |
| Sep 30, 2022 | -1.36 |
| Jun 30, 2022 | -1.94 |
| Mar 31, 2022 | -1.03 |
| Dec 31, 2021 | -1.67 |
| Sep 30, 2021 | -1.12 |